鶹ýɫƬ

Journal News

The ‘phospho-dawn’ of circadian clock proteomics

Nivedita Uday Hegdekar
March 9, 2022

As a Ph.D. student at the University of Edinburgh, was interested in researching circadian rhythms, which are key physiological changes that follow a 24-hour cycle. These natural processes respond primarily to light and dark and affect most living things, including animals, plants and microbes. She joined ’s lab, which researched how circadian rhythms are developed and affect plant life from the cell to the ecosystem.

Circadian clock

Most genetic studies in circadian biology research have focused on gene expression levels. However, protein abundance and post-translational modifications tell a larger story about circadian rhythms, making it essential to study these changes as well.

“Many transcription factor proteins that genetically control circadian rhythms also undergo post-translational modifications,” Krahmer said. “One such modification —protein phosphorylation — is involved in the circadian clock mechanism not only in plants but also in fungi and eukaryotes.”

Krahmer was interested in investigating circadian rhythms in protein abundance and phosphorylation PTM changes in a normally functioning circadian clock system. She used mass spectrometry to generate global proteomics and phosphoproteomics datasets on circadian time courses in the Arabidopsis thaliana plant.

“We found that about 0.4% of global proteins but a much larger percentage of the quantified phosphorylation sites were altered due to the circadian clock,” Krahmer said. “Furthermore, approximately half of these rhythmic phosphosites were most phosphorylated at dawn, a pattern we termed the ‘phospho-dawn.’”

Krahmer discovered that many phosphorylated proteins are those involved in circadian clock regulation, such as MAPK, CK2 and GSK. She also showed that the genetic clock circuit is required for most rhythmic protein phosphorylation.

Using an Arabidopsis thaliana plant line with a disabled clock gene circuit, Krahmer found that most of the most circadian protein phosphorylation was lacking. However, a few phosphorylation sites that fluctuated despite the disabled circadian clock still tended to peak in abundance close to subjective dawn.

“This may suggest that the canonical circadian mechanism is necessary for most but perhaps not all protein phosphorylation rhythms,” Krahmer said.

To exemplify in an experimental approach how circadian phosphorylation of a protein can be linked to its function, she analyzed the effect of a mutation in the phosphorylation site on the activity of the metabolic enzyme F2KP (one of the identified proteins in her data sets). F2KP is one of the regulators of carbon partitioning into starch and sucrose. It is necessary to maintain normal growth in fluctuating light conditions. Krahmer showed that the phosphorylated serine of F2KP has functional relevance in plant metabolism. Her findings .

Following her Ph.D., Krahmer pursued postdoctoral research in ’s lab at the University of Edinburgh and now works at ’s lab at the University of Lausanne. Her research interests have expanded to the role of metabolism in photobiology.

“If there is one major takeaway message from my Ph.D. work,” she said, “it’s that that protein changes and PTMs should be an important part of circadian biology research.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nivedita Uday Hegdekar

Nivedita Uday Hegdekar is a recent Ph.D. graduate in biochemistry and molecular biology from the University of Maryland, Baltimore.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.